A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients with Completely Resected Stage I or IIA
Non-Squamous Non-Small Cell Lung Cancer
Identified as High or Intermediate Risk by a 14-Gene Prognostic Assay


Lungenkrebszentrum Ostercappeln, Sektion Thoraxchirurgie, Franziskus Hospital Harderberg

Niels Stensen Kliniken
Alte Rothenfelder Strasse 23
49124 Georgsmarienhütte

Dr. Petra Hoffknecht
Franziskus Hospital Harderberg

Vorherige Studie
Nächste Studie
to top icon